Chia‐Hao Su

4.7k total citations · 1 hit paper
91 papers, 4.0k citations indexed

About

Chia‐Hao Su is a scholar working on Biomedical Engineering, Materials Chemistry and Biomaterials. According to data from OpenAlex, Chia‐Hao Su has authored 91 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Biomedical Engineering, 33 papers in Materials Chemistry and 24 papers in Biomaterials. Recurrent topics in Chia‐Hao Su's work include Nanoplatforms for cancer theranostics (31 papers), Nanoparticle-Based Drug Delivery (23 papers) and Gold and Silver Nanoparticles Synthesis and Applications (9 papers). Chia‐Hao Su is often cited by papers focused on Nanoplatforms for cancer theranostics (31 papers), Nanoparticle-Based Drug Delivery (23 papers) and Gold and Silver Nanoparticles Synthesis and Applications (9 papers). Chia‐Hao Su collaborates with scholars based in Taiwan, United States and Italy. Chia‐Hao Su's co-authors include Chen‐Sheng Yeh, Weipeng Li, Fong-Yu Cheng, Suresh Thangudu, Ming‐Fong Tsai, Vijayakumar Shanmugam, Yu‐Sheng Cheng, Shih-Hui Gilbert Chang, Chih-Chia Huang and Hwo‐Shuenn Sheu and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Nature Communications.

In The Last Decade

Chia‐Hao Su

87 papers receiving 3.9k citations

Hit Papers

Ultrasound-Induced Reactive Oxygen Species Mediated Thera... 2015 2026 2018 2022 2015 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chia‐Hao Su Taiwan 33 2.2k 1.8k 1.1k 712 519 91 4.0k
Jelena Kolosnjaj‐Tabi France 27 2.5k 1.1× 1.4k 0.7× 1.8k 1.6× 735 1.0× 484 0.9× 49 4.0k
Bingbo Zhang China 45 2.4k 1.1× 2.6k 1.4× 1.0k 0.9× 1.3k 1.8× 416 0.8× 150 4.9k
Yi Hou China 35 2.4k 1.1× 2.1k 1.1× 1.2k 1.1× 1.4k 1.9× 303 0.6× 154 5.0k
Bella B. Manshian Belgium 31 1.9k 0.9× 2.7k 1.5× 1.3k 1.2× 1.0k 1.4× 406 0.8× 81 4.8k
Shizhu Chen China 29 2.6k 1.2× 1.5k 0.9× 1.3k 1.1× 1.0k 1.4× 160 0.3× 47 4.0k
Xiuli Yue China 39 3.0k 1.4× 1.7k 1.0× 1.3k 1.2× 1.1k 1.6× 536 1.0× 88 4.7k
Sheng Tong United States 27 2.0k 0.9× 952 0.5× 1.6k 1.4× 1.0k 1.5× 335 0.6× 59 3.8k
Chuang LIU China 42 2.6k 1.2× 2.1k 1.1× 831 0.7× 1.5k 2.2× 197 0.4× 127 5.3k
Weisheng Guo China 41 3.4k 1.6× 2.4k 1.3× 1.4k 1.2× 1.7k 2.3× 320 0.6× 107 5.9k

Countries citing papers authored by Chia‐Hao Su

Since Specialization
Citations

This map shows the geographic impact of Chia‐Hao Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chia‐Hao Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chia‐Hao Su more than expected).

Fields of papers citing papers by Chia‐Hao Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chia‐Hao Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chia‐Hao Su. The network helps show where Chia‐Hao Su may publish in the future.

Co-authorship network of co-authors of Chia‐Hao Su

This figure shows the co-authorship network connecting the top 25 collaborators of Chia‐Hao Su. A scholar is included among the top collaborators of Chia‐Hao Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chia‐Hao Su. Chia‐Hao Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Wei‐Chia, Steve Lu, Chia‐Hao Su, et al.. (2025). Tadalafil Ameliorates Chronic Ischemia-Associated Bladder Overactivity in Fructose-Fed Rats by Exerting Pelvic Angiogenesis and Enhancing p-eNOS Expression. International Journal of Molecular Sciences. 26(3). 1363–1363. 1 indexed citations
2.
Lian, Wei‐Shiung, Re‐Wen Wu, Chia‐Hao Su, et al.. (2024). Iodinated gadolinium-gold nanomaterial as a multimodal contrast agent for cartilage tissue imaging. APL Bioengineering. 8(3). 36110–36110. 3 indexed citations
3.
Wu, Re‐Wen, et al.. (2024). Gold nanomaterials capped with bovine serum albumin for cell and extracellular vesicle imaging. Nanotechnology. 36(10). 105101–105101.
4.
Chen, Hui‐Wen, et al.. (2024). Imbalance in Unc80 RNA Editing Disrupts Dynamic Neuronal Activity and Olfactory Perception. International Journal of Molecular Sciences. 25(11). 5985–5985. 1 indexed citations
5.
Chen, Ying‐Chi, Yiting Li, Wei‐Che Lin, et al.. (2023). Electroactive membrane fusion-liposome for increased electron transfer to enhance radiodynamic therapy. Nature Nanotechnology. 18(12). 1492–1501. 36 indexed citations
6.
Chiou, Pei‐Yu, Yi‐Hsuan Wu, Ying‐Chi Chen, et al.. (2023). Prussian blue analog with separated active sites to catalyze water driven enhanced catalytic treatments. Nature Communications. 14(1). 4709–4709. 42 indexed citations
7.
Thangudu, Suresh, et al.. (2023). Ligand free FeSn2 alloy nanoparticles for safe T2-weighted MR imaging of in vivo lung tumors. Biomaterials Science. 11(6). 2177–2185. 3 indexed citations
8.
Thangudu, Suresh, et al.. (2023). Biocompatible Cerium Carbonate-Based Nanozymes for Oxidase Activity, Sensing, Computed Tomography Contrast, and Delivery of Small Molecules. ACS Applied Nano Materials. 6(14). 12922–12932. 3 indexed citations
9.
Su, Guan-Lin, Po‐Ya Chang, Suresh Thangudu, et al.. (2022). Chemical Structure and Shape Enhance MR Imaging-Guided X-ray Therapy Following Marginative Delivery. ACS Applied Materials & Interfaces. 14(11). 13056–13069. 12 indexed citations
10.
Thangudu, Suresh, et al.. (2022). Magnetic, biocompatible FeCO3 nanoparticles for T2-weighted magnetic resonance imaging of in vivo lung tumors. Journal of Nanobiotechnology. 20(1). 157–157. 23 indexed citations
11.
Thangudu, Suresh, et al.. (2022). Safe magnetic resonance imaging on biocompatible nanoformulations. Biomaterials Science. 10(18). 5032–5053. 24 indexed citations
13.
Chen, Ying‐Chi, et al.. (2022). Engineering H2O2 and O2 Self‐Supplying Nanoreactor to Conduct Synergistic Chemiexcited Photodynamic and Calcium‐Overloaded Therapy in Orthotopic Hepatic Tumors. Advanced Healthcare Materials. 11(20). e2201613–e2201613. 38 indexed citations
14.
Thangudu, Suresh & Chia‐Hao Su. (2021). Peroxidase Mimetic Nanozymes in Cancer Phototherapy: Progress and Perspectives. Biomolecules. 11(7). 1015–1015. 53 indexed citations
15.
Lin, Chin‐Wei, et al.. (2021). Improvement of multisource localization of magnetic particles in an animal. Scientific Reports. 11(1). 9628–9628. 1 indexed citations
16.
Tsai, Ming‐Fong, Yu‐Lun Lo, Chun‐Chieh Yu, et al.. (2020). <p>Multi-Stimuli-Responsive DOX Released from Magnetosome for Tumor Synergistic Theranostics</p>. International Journal of Nanomedicine. Volume 15. 8623–8639. 16 indexed citations
17.
Thangudu, Suresh, Fong‐Yu Cheng, & Chia‐Hao Su. (2020). Advancements in the Blood–Brain Barrier Penetrating Nanoplatforms for Brain Related Disease Diagnostics and Therapeutic Applications. Polymers. 12(12). 3055–3055. 50 indexed citations
19.
Chen, Wei‐Yu, Ya‐Jen Chang, Chia‐Hao Su, et al.. (2016). Upregulation of Interleukin-33 in obstructive renal injury. Biochemical and Biophysical Research Communications. 473(4). 1026–1032. 46 indexed citations
20.
Chang, Alice Y., et al.. (2014). Interplay between brain stem angiotensins and monocyte chemoattractant protein-1 as a novel mechanism for pressor response after ischemic stroke. Neurobiology of Disease. 71. 292–304. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026